Markets

Tactile Systems Technology Inc. (TCMD), Interview with Gerald R. Mattys, CEO

Watch the CEO Signature Series interview with Gerald R. Mattys, Chief Executive Officer of Tactile Systems Technology Inc. (TCMD).

Gerald R. Mattys, CEO

Gerald R. Mattys, CEO

CEO Bio:

Previous leadership roles include: CEO, Medisyn Technologies; CEO, Timm Medical; VP/GM, Mallinckrodt; VP/GM, Nellcor Puritan Bennett

Company Description:

Tactile Systems Technology, Inc. ("Tactile Medical") is a medical technology company that develops and provides innovative medical devices for the treatment of chronic diseases at home. The Company is the sole manufacturer and distributor of the Flexitouch and Entré Systems, medical devices to help control symptoms of lymphedema, a chronic and progressive medical condition that is often an unintended consequence of cancer treatment, and the ACTitouch System, a medical device to treat venous leg ulcers and chronic venous insufficiency. The Company provides products for use both in the home and in health care institutions, including hospitals and vascular, wound and lymphedema clinics throughout the United States. For additional information, please visit www.tactilemedical.com. To receive future press releases via email, please visit Investors.tactilemedical.com.

About Nasdaq:

Nasdaq (NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today’s global capital markets. As the creator of the world’s first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,500 listed companies with a market value of over $8.8 trillion and more than 10,000 corporate clients. To learn more, visit www.nasdaq.com/ambition or www.nasdaqomx.com.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

TCMD

Other Topics

Technology Leadership Investing